Jeffrey P Ciavarri

This inventor holds 13 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Millennium Pharmaceuticals Limited, University of Pennsylvania. Active years: 2009-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey P Ciavarri. Retrieved from https://idiyas.com/inventor/jeffrey-p-ciavarri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 69.2

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 8.3

ph-index = 3

Forward Citations = 52(Granted Patents)

Company Filing History:

12 out of 854

Millennium Pharmaceuticals Limited

patents

1 out of 2,659

University of Pennsylvania

patents

Years Active: 2009-2020

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10538533 - Heteroaryls and uses thereof (2020-01-21),

2. 10202389 - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme (2019-02-12),

3. 10202373 - Heteroaryls and uses thereof (2019-02-12),

4. 9802960 - Heteroaryls and uses thereof (2017-10-31),

5. 9796725 - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme (2017-10-24),

6. 9751854 - Heteroaryls and uses thereof (2017-09-05),

7. 9663525 - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme (2017-05-30),

8. 9321731 - Substituted hydroxamic acids and uses thereof (2016-04-26),

9. 9290500 - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme (2016-03-22),

10. 9096518 - Substituted hydroxamic acids and uses thereof (2015-08-04),

11. 8268822 - 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases (2012-09-18),

12. 7732444 - 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases (2010-06-08),

13. 7485631 - Phorboxazole compounds and methods of their preparation (2009-02-03),

Title: Inventor Profile: Jeffrey P. Ciavarri

Introduction

Jeffrey P. Ciavarri is an accomplished inventor based in Reading, Massachusetts, USA. With a remarkable portfolio of 13 patents, he has significantly contributed to the field of pharmaceutical developments, particularly in the area of compound formulations that address various medical conditions.

Latest Patents

Among his latest innovations are notable patents concerning heteroaryls and their therapeutic uses. One patent outlines a compound formula that comprises pharmaceutically acceptable salts, specifically designed as inhibitors of VPS34. This groundbreaking work holds promise for treating proliferative, inflammatory, and cardiovascular disorders, showcasing the relevance of his inventions in contemporary medical treatments.

Career Highlights

Over the years, Jeffrey has built his career by working with reputable organizations such as Millennium Pharmaceuticals Limited and the University of Pennsylvania. His experience in these institutions has enriched his knowledge and expertise, allowing him to innovate effectively within the pharmaceutical landscape.

Collaborations

Throughout his career, Jeffrey has worked alongside esteemed colleagues, including Paul E. Fleming and Indu T. Bharathan. These collaborations have been pivotal in enhancing his research efforts and expanding the impact of his innovations in the field.

Conclusion

Jeffrey P. Ciavarri stands out as a dynamic inventor whose contributions to pharmaceutical research are noteworthy. With a strong background and a commitment to addressing significant health challenges through his patented inventions, he continues to leave a substantial mark in the world of innovation.

Profile summary based on public USPTO records.